HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

DECA-14

an antineoplastic agent; structure in first source

Also Known As:

dequalinium analogue, C-14 linker; dequalinium-14

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Quinolinium Compounds: 1
        Dequalinium: 88
        DECA-14: 2

Experts

1.	Rotenberg, Susan A: 2 articles (09/2015 - 09/2010)
2.	Alishekevitz, Dror: 1 article (09/2015)
3.	Bril, Rotem: 1 article (09/2015)
4.	Daniel, Shahar: 1 article (09/2015)
5.	Kaidar-Person, Orit: 1 article (09/2015)
6.	Kotsofruk, Ruslana: 1 article (09/2015)
7.	Miller, Valeria: 1 article (09/2015)
8.	Nevelsky, Alexander: 1 article (09/2015)
9.	Rachman-Tzemah, Chen: 1 article (09/2015)
10.	Raviv, Ziv: 1 article (09/2015)

Related Diseases

1.	Tics (Tic) 09/01/2010 - "DECA-14 and rapamycin were identified as NB TIC-selective agents. "
2.	Neoplasms (Cancer) 09/29/2015 - "Finally, the anti-tumor agent, dequalinium-14, in addition to its anti-tumor effect, reduces macrophage motility, inhibits macrophage infiltration of irradiated tumors and reduces the extent of metastasis in locally irradiated mice. "
3.	Neoplasm Metastasis (Metastasis) 09/29/2015 - "Finally, the anti-tumor agent, dequalinium-14, in addition to its anti-tumor effect, reduces macrophage motility, inhibits macrophage infiltration of irradiated tumors and reduces the extent of metastasis in locally irradiated mice. "

Related Drugs and Biologics

1.	Sirolimus (Rapamycin)